Journal
REPRODUCTION
Volume 138, Issue 2, Pages 309-317Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/REP-08-0299
Keywords
-
Categories
Funding
- Grant-in-Aid for Creative Scientific Research [13GS0008]
- Ministry of Education, Science, Sports, Culture, and Technology of Japan
- BioGreen21
- RDA [2007040103401]
- Korea Biotech R&D Group of Next-generation growth engine project [F104D01002-07A0401-0023]
- ministry of Education, Science and Technology, Republic of Korea
Ask authors/readers for more resources
Since the birth of Cumulina, the first mouse clone produced by somatic cell nuclear transfer (SCNT), the success rate of cloning in mice has been extremely low compared with other species and most of the inbred mouse strains have never been cloned. Recently, our laboratory has found that treatment of SCNT mouse embryos with trichostatin A, a histone deacetylase inhibitor (HDACi), improved the full-term development of B6D2F1 mouse clones significantly. However, this was not effective for the inbred strains. Here, we show for the first time that by treating SCNT embryos with another HDACi, scriptaid, all the important inbred mouse strains can be cloned, such as C57BL/6, C3H/He, DBA/2, and 129/Sv. Moreover, the success of somatic nuclear reprogramming and cloning efficiency via nuclear transfer technique is clearly linked to the competent de novo synthesis of nascent mRNA in cloned mouse embryos. Reproduction (2009) 138 309-317
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available